Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.
Knoll
Greg A
GA
Division of Nephrology, Clinical Epidemiology Program, The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, USA.
Blydt-Hansen
Tom D
TD
Campbell
Patricia
P
Cantarovich
Marcelo
M
Cole
Edward
E
Fairhead
Todd
T
Gill
John S
JS
Gourishankar
Sita
S
Hebert
Diane
D
Hodsman
Anthony
A
House
Andrew A
AA
Humar
Atul
A
Karpinski
Martin
M
Kim
S Joseph
SJ
Mainra
Rahul
R
Prasad
G V Ramesh
GV
D002170:Canada; D015897:Comorbidity; D003404:Creatinine / Q000097:blood; D020031:Epstein-Barr Virus Infections / Q000453:epidemiology; D005298:Fertility; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000592:standards; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007674:Kidney Diseases / Q000601:surgery; D016030:Kidney Transplantation; D008991:Monitoring, Physiologic / Q000592:standards; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D011182:Postoperative Care / Q000592:standards*; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014611:Vaccination / Q000592:standards
D007166:Immunosuppressive Agents; D053918:Papillomavirus Vaccines; D003404:Creatinine